{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:34:05Z","timestamp":1770064445201,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T00:00:00Z","timestamp":1370649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40291-013-0041-8","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:45:23Z","timestamp":1370591123000},"page":"319-326","source":"Crossref","is-referenced-by-count":26,"title":["The Effect of Uridine Diphosphate Glucuronosyltransferase (UGT)1A6 Genetic Polymorphism on Valproic Acid Pharmacokinetics in Indian Patients with Epilepsy: A Pharmacogenetic Approach"],"prefix":"10.1007","volume":"17","author":[{"given":"Murali","family":"Munisamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Behari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barghavi","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiyagu","family":"Rajakannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surulivel Rajan","family":"Mallayasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivekanandhan","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,8]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1046\/j.1528-1157.2002.t01-1-26901.x","volume":"43","author":"IA Kotsopoulos","year":"2002","unstructured":"Kotsopoulos IA, Van Merode T, Kessels FG, Krom MC, Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia. 2002;43:1402\u20139.","journal-title":"Epilepsia"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","volume":"61","author":"JW Sander","year":"1996","unstructured":"Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996;61:433\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","volume":"7","author":"EK St Louis","year":"2009","unstructured":"St Louis EK. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol. 2009;7:106\u201314.","journal-title":"Curr Neuropharmacol"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"384","author":"WE Evans","year":"2003","unstructured":"Evans WE, McLeod HL. Pharmacogenomics, drug disposition, drug targets, and side effects. N Engl J Med. 2003;384:538.","journal-title":"N Engl J Med"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-198510020-00003","volume":"10","author":"DW Chadwick","year":"1985","unstructured":"Chadwick DW. Concentration-effect relationships of sodium valproate. Clin. Pharmacokinet. 1985;10:155\u201363.","journal-title":"Clin. Pharmacokinet"},{"key":"41_CR6","first-page":"589","volume-title":"Antiepileptic drugs","author":"TL Baillie","year":"1995","unstructured":"Baillie TL, Sheffels PR. Valproate: chemistry and biotransformation. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic drugs. 4th ed. New York: Raven Press; 1995. p. 589\u2013604.","edition":"4"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0024-3205(95)02073-R","volume":"57","author":"B Burchell","year":"1995","unstructured":"Burchell B, Brierley CH, Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci. 1995;57:1819\u201331.","journal-title":"Life Sci"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","volume":"1","author":"CD King","year":"2000","unstructured":"King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyltransferases. Curr Drug Metab. 2000;1:143\u201361.","journal-title":"Curr Drug Metab"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1054-3589(08)60758-9","volume":"42","author":"B Burchell","year":"1998","unstructured":"Burchell B, Brierley CH, Monaghan G. The structure and function of the UDP-glucuronosyltransferase gene family. Adv Pharmacol. 1998;42:335\u20138.","journal-title":"Adv Pharmacol"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","volume":"7","author":"PI Mackenzie","year":"1997","unstructured":"Mackenzie PI, Owens IS, Burchell B. The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 1997;7:255\u201369.","journal-title":"Pharmacogenetics"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/carcin\/15.8.1549","volume":"15","author":"A Orzechowski","year":"1994","unstructured":"Orzechowski A, Schrenk D, Bock-Hennig BS, Bock KW. Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex. Carcinogenesis. 1994;15:1549\u201353.","journal-title":"Carcinogenesis"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj2780465","volume":"278","author":"R Woosterk","year":"1991","unstructured":"Woosterk R, Sutherland L, Ebner T, Clarke D, Da Cruz e Silva O, Burchell B. Cloning and stable expression of a new member of the human liver phenol\/ bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem J. 1991;278:465\u20139.","journal-title":"Biochem J"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008571-199712000-00007","volume":"7","author":"M Ciotti","year":"1997","unstructured":"Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics. 1997;7:485\u201395.","journal-title":"Pharmacogenetics"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1124\/jpet.104.081968","volume":"313","author":"S Krishnaswamy","year":"2005","unstructured":"Krishnaswamy S, Hao Q, Al-Rohaimi A. UDP glucuronosyltransferase (UGT)1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ther. 2005;313:1340\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1520\/JFS13711J","volume":"39","author":"CT Comey","year":"1994","unstructured":"Comey CT, Koons BW, Presley KW, Smerick JB, Sobieralski CA, Stanley DM. DNA extraction strategies for amplified fragment length polymorphism analysis. J Forensic Sci. 1994;39:1254\u201369.","journal-title":"J Forensic Sci"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00008571-200406000-00004","volume":"14","author":"M Verlaan","year":"2004","unstructured":"Verlaan M, Morsche RH, Pap A, et al. Functional polymorphisms of UDP-glucuronosyltransferases 1A1, 1A6 and 1A8 are not involved in chronic pancreatitis. Pharmacogenetics. 2004;14:351\u20137.","journal-title":"Pharmacogenetics"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchromb.2005.11.028","volume":"830","author":"H Amini","year":"2006","unstructured":"Amini H, Javan M, Ahmadiani A. Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;830:368\u201371.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"41_CR18","first-page":"378","volume":"58","author":"P Kishore","year":"2003","unstructured":"Kishore P, Rajani Kumar V, Satyanarayana V, Krishna DR. HPLC determination of valproic acid in human serum. Pharmazie. 2003;58:378\u201380.","journal-title":"Pharmazie"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1006990925122","volume":"19","author":"TA Ketter","year":"1999","unstructured":"Ketter TA, Frye MA, Cora-Locatelli G, Kimbrell TA. Metabolism and excretion of mood stabilizers and new anticonvulsants. Cell Mol Neurobiol. 1999;19:511\u201332.","journal-title":"Cell Mol Neurobiol"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.fpc.0000114771.78957.cb","volume":"14","author":"S Nagar","year":"2004","unstructured":"Nagar S, Zalatoris JJ, Blanchard RL. Human UGT 1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics. 2004;14:487\u201399.","journal-title":"Pharmacogenetics"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008571-199906000-00009","volume":"9","author":"JW Lampe","year":"1999","unstructured":"Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum Bilirubin concentrations. Pharmacogenetics. 1999;9:341\u20139.","journal-title":"Pharmacogenetics"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","volume":"15","author":"G Zaccara","year":"1998","unstructured":"Zaccara G, Messori A, Moroni F. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet. 1998;15:367\u201389.","journal-title":"Clin Pharmacokinet"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2710.2002.00440.x","volume":"27","author":"HM Park","year":"2002","unstructured":"Park HM, Kang SS, Lee YB, Shin DJ, Kim ON, Lee SB, et al. Population pharmacokinetics of intravenous valproic acid in Korean patients. J Clin Pharm Ther. 2002;27:419\u201325.","journal-title":"J Clin Pharm Ther"},{"key":"41_CR24","volume-title":"Antiepileptic drugs","author":"RH Levy","year":"2002","unstructured":"Levy RH, Mattson RH, Meldrum BS, Perucca E. Antiepileptic drugs. 5th ed. New York: Raven Press; 2002.","edition":"5"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00561557","volume":"8","author":"F Schobben","year":"1975","unstructured":"Schobben F, van Der Kleijn E, Gabreels JM. Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol. 1975;8:97\u2013105.","journal-title":"Eur J Clin Pharmacol"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","volume":"68","author":"XM Chu","year":"2012","unstructured":"Chu XM, Zhang LF, Wang GJ, Zhang SN, Zhou JH, Hao HP. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. Eur J Clin Pharmacol. 2012;68:1395\u2013401.","journal-title":"Eur J Clin Pharmacol"},{"key":"41_CR27","first-page":"429","volume":"12","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao L, Liu YP, Huang NN, Xu SJ, Ma DJ. Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12:429\u201332.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-013-0041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-013-0041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-013-0041-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T22:19:34Z","timestamp":1563142774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-013-0041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,8]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s40291-013-0041-8","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,8]]}}}